What is Non-Clinical Regulatory Writing?
In the pharmaceutical industry, precision, compliance, and scientific clarity are critical at every stage of drug development. Among the most vital, though least used roles in this process, is non-clinical regulatory writing, a medical writing type in which accurate non-clinical information is conveyed to world regulatory authorities.
What is a Risk Management Plan (RMP) ?
A Risk Management Plan (RMP) is a detailed report that the pharmaceutical industry needs to make sure the benefits of a pharmaceutical product exceed its dangers. It is a required component of regulatory submission, especially in the European Union, and is a key element of the product lifecycle, i.e., development to post-marketing surveillance.
What is Orphan Drug Designation (ODD)?
Orphan Drug Designation (ODD) is a regulatory designation that applies to those types of medicine which have been specifically designed to treat a rare disease commonly referred to as an orphan disease. These diseases affect a small fraction of the population, and because of the limited market potential, pharmaceutical companies historically had little incentive to develop treatments.
What is Pharmacovigilance System Setup?
Pharmacovigilance (PV) is an important part of the pharmaceutical sector as it plays a crucial role in ensuring safety of medicinal products in their lifecycle. Marketing Authorization Holder (MAH) and clinical research organizations (CROs) are obliged to establish a compliant pharmacovigilance system in accordance with the requirements of global regulations.
What is Pharmacovigilance Audit?
Patient safety and compliance with the regulations are the most important in the pharmaceutical industry. One of the key mechanisms to ensure that drug safety processes are effective, consistent, and compliant is the pharmacovigilance audit. This internal or external assessment assists with the evaluation of the strength of the pharmacovigilance system, identification of risk areas, and the proper monitoring of medicinal products during the lifecycle.